Melanie Morel-Ferris
Overview
Melanie Morel-Ferris received $383K in total compensation, including $159K in salary, at InVivo Therapeutics Holdings in 2017.
Source: SEC filing on April 27, 2018.
Related executives
We found 16 more executives who work or worked at InVivo Therapeutics Holdings.
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
Richard Christopher
InVivo Therapeutics Holdings
Chief Financial Officer
Heather Hamel
InVivo Therapeutics Holdings
Chief Legal Officer
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
Pamela Stahl
InVivo Therapeutics Holdings
Former Chief Commercial Officer
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
Tamara Joseph
InVivo Therapeutics Holdings